COVID-19 has many names; Coronavirus, Covid-19 or SARS-CoV-2. Worldwide pandemic triggered by this virus has prompted an unprecedented amount..

Global biosimilar market is currently driven by presence of a large geriatric population and increase in the prevalence..

An Indian generic pharmaceutical giant was keen on developing in-house biosimilars to expand its portfolio in the domestic as well as global markets.

how technical writing opportunities have proliferated in the drug development market in India..

As the regulatory landscape is evolving for biosimilars, the intriguing challenges for the biosimilar development companies and manufacturers..

October being the Breast Cancer awareness month, we thought that a discussion on breast cancer in India would be most appropriate to start the IBPS blog